Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 12, 2013Leukemia & lymphoma/Leukemia and lymphomaOpen Access

Modeling progression risk for smoldering multiple myeloma: results from a prospective clinical study

View Full Paper
Ask AI
Bookmark
Share

Authors

BCBenjamin M. CherryYale UniversityNKNeha KordeMemorial Sloan Kettering Cancer CenterMKMary KwokUniversity of Washington

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Cherry et al. (2013) studied this question.

synapsesocial.com/papers/6a1d2801ba3016ff712f2c0fhttps://doi.org/10.3109/10428194.2013.764419
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategies2011 · 204 citations
  2. 2Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma2007 · 934 citations
  3. 3From Myeloma Precursor Disease to Multiple Myeloma: New Diagnostic Concepts and Opportunities for Early Intervention2011 · 86 citations
  4. 4New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells2007 · 588 citations
  5. 5Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance2005 · 705 citations